Package 68462-110-10

{"route": ["ORAL"], "spl_id": "2068fcde-8e47-4ced-a038-b00c04dcceb8", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "upc": ["0368462109601", "0368462153604", "0368462110607"], "unii": ["0H73WJJ391"], "rxcui": ["151226", "199888", "199889", "199890"], "spl_set_id": ["35312f49-decf-428d-bf5f-4215b762ed3c"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (68462-110-05)", "package_ndc": "68462-110-05", "marketing_start_date": "20200730"}, {"sample": false, "description": "1000 TABLET, FILM COATED in 1 BOTTLE (68462-110-10)", "package_ndc": "68462-110-10", "marketing_start_date": "20090327"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (68462-110-60)", "package_ndc": "68462-110-60", "marketing_start_date": "20090327"}], "brand_name": "Topiramate", "product_id": "68462-110_2068fcde-8e47-4ced-a038-b00c04dcceb8", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "68462-110", "generic_name": "Topiramate", "labeler_name": "Glenmark Pharmaceuticals Inc., USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "200 mg/1"}], "application_number": "ANDA077627", "marketing_category": "ANDA", "marketing_start_date": "20090327", "listing_expiration_date": "20271231"}